IL2 and metabolic dysfunction-associated steatotic liver disease: However, a meta-analysis did not find difference in circulating IL-2 between NAFLD and controls [27]; this may imply that circulating IL-2 levels do not mirror the hepatic expression of IL-2, thus, possibly IL-2 may not be utilized for the non-invasive diagnosis of MASLD.